Prepared for Nuritas

Category Authority

Up the chain. From an ingredient people buy to the name they look for.

July 2026

How we see you

The science is a decade ahead.
The shelf it sits on is not.

Two Nuritas

The mismatch

The lab on Dawson Street, the AI platform and the people in it look like a frontier science company. The products end up beside six pound supplements that promise the same things and prove none of them. Everything below follows from closing that gap.

$80bn

The space below the needle, measured

GLP-1 injectables are roughly an eighty billion dollar market in 2026 and forecast to more than double by 2033. Directly beneath them sits the evidenced, ingestible, no-prescription layer: around five to seven billion today. Same biology, a fraction of the size, and nobody has named it or claimed the authority to speak for it. That is the category to define and then own.

The test

How you tell it is enough

A category is only worth owning if it has a door with a lock on it. Ours: proven in human clinical trials, ingestible rather than injected, no prescription required, and a traceable source. Nuritas passes all four, with trials run alongside Stanford Sports Medicine. Almost nothing on the shelf below does. Set that test publicly and it separates you from the dross by definition rather than by argument.

Caught up

Why now, after sixteen years

You were doing this before AI was a category anyone marketed, and the discovery platform is European, built and governed to European standards at a moment when that has become a reason to buy rather than a footnote. The science, the interest and the technology have arrived where you already were. That is an inflection point, and it needs saying out loud.

The Ask

Move up the chain. Become the name inside.

FIRST: THE INGREDIENT BRAND

Intel inside, for functional food and beauty.

Some ingredients earn enough trust that the brand using them puts the name on the front of the pack. Creatine and collagen suppliers did it. Kerry built a world-leading business on it, out of Ireland. That is the position: a premium parent brand carrying the proof, and premium here means measured rather than merely expensive, with every claim tied to a trial anyone can check.

THEN: THE AUTHORITY

The people the serious buyers ask about peptides.

A European programme built to land harder in the United States, not instead of it. Dublin, London and Amsterdam give you a European science and regulatory base, which is the strongest possible platform for a category defined by evidence, and American buyers and investors take a European standard more seriously than another New York consumer campaign. Sovereign AI developed to European standards is part of that argument, not a separate one: where the model runs, whose rules it answers to and who owns the discovery all matter to the partners you want.

The Approach

Four things worth doing.
You own them. We make them land.

00 · How to read this

Recommendations, not a production contract

These are the activities we think are worth running. You decide which of them you want and you own them. Our job is the part either side: making sure the right people come, that it is covered while it happens, and that someone makes sense of it afterwards. That is exactly what we did across the first five years of Intercom, and it is where an agency actually earns its money.

01 · Teaching

A series that makes Nuritas the explainer

Intercom built enormous authority running On Product, a plain teaching series that made them the people who explained the category. The same applies here. Virtual and in person, aimed at formulators, brand teams and the trade, with Nora doing what she does better than anyone, which is explaining the science honestly and without hype. We build the audience, place the coverage around it and turn each session into something that keeps earning.

02 · The lab

Dublin as the thing people have to see

The lab is more persuasive than any trade stand, and cheaper. A working press and partner tour, with a virtual version for the people who cannot travel. Bring the right journalists and the right buyers into the room where the discovery actually happens and let it do the work. We handle who comes, what they leave understanding and what gets written.

03 · Convening

Own the room, not just a stand at someone else’s

A Nuritas-convened event on evidenced peptides, with the serious end of the market in the room. If Eli Lilly and Novo Nordisk are discussing the clinical high end, the company that convened the conversation is the one the market remembers. We handle the invitations, the press before, during and after, and the follow-through.

04 · Moments

The announcements you already have coming

The new Chief Brand Officer appointment is a genuine business story and it is ready now, before any rebrand. It sets the tone for what follows and proves the machine works. Then the milestones after it, each planned as a campaign rather than a single day.

Investment

Six months. Judged at a hundred days.

€10,750 / month

Monthly retainer

A six month engagement at a flat monthly fee, EUR 64,500 in total, exclusive of VAT. Reviewed formally at one hundred days, with everything we have committed to below measured against what actually happened. If we cannot show you something real by then, we should not be here for the second half.

WHAT THE PROGRAMME COVERS

◆ A dedicated London and Dublin account team
◆ Positioning, category and messaging work
◆ European and international media relations
◆ Founder profiling and media preparation
◆ Press and partner programme around your owned activities
◆ The appointment announcement and the milestones after it
◆ Third party production, venue and research costs are charged separately at cost

WHAT WE COMMIT TO

2-3

Tier 1 and business media, per quarter

European and international business and technology media. A floor, not a ceiling.

4-6

Trade and industry, per quarter

Ingredients, functional food and health and beauty trade, where your buyers read.

2

Owned activities supported

Two of the activities above taken from plan to coverage across the six months.

100 days

First formal review

Everything above measured, in writing, before you commit to the back half.

Fees quoted exclusive of VAT. EUR 10,750 per month across six months.
The activities described are recommendations. You own and run them; we handle the audience, the coverage and the follow-through.

About Beachhut

15 years inside tech.

Founded in Dublin by Paul Hayes. Now Dublin, London, Belfast and Amsterdam. Deep technology is the core of what we do: quantum computing, Dexcom, and the EU climate pact.

We specialise in earned media for tech, fintech, deeptech, medtech, mobility, AI and the professional services firms that serve them. Quality over quantity, tailored stories, smart amplification.

What sets us apart: we understand tech.

No learning curve. We know what works at every stage, from seed to unicorn, and we know the people who matter to you.

Dublin, London, Belfast, Amsterdam

15 yrs

in tech communications

European

built to land harder in the US

Earned

media-first, no paid amplification

Sector

tech, fintech, deeptech, medtech, AI, mobility

Your Team

Senior people. Founder-led.

Megan Hill

UK Lead

Lead Dublin

Alex

Senior Account Manager

London

Your Strategic Team

Paul Hayes

Founder

Dublin

Niall McLoughlin

CEO

Dublin

Case Study

Global launch for Ireland's first silicon quantum computer.

A deeptech Irish spin-out, taken to a global stage around its raise.

Full-stack PR for Equal1, Ireland's only quantum computing company, through a $60m raise and the global launch of the UnityQ silicon quantum server. Mainstream, business and deeptech media across Ireland, the UK and Europe.

Selected coverage · click to expand

PR OBJECTIVES

Land the $60m raise across tier-one business, tech and deeptech press, in Ireland and internationally.
Make hard technology legible: silicon quantum and the UnityQ chip, explained so investors and buyers get it.
Position Equal1 as a global leader in the quantum computing revolution, alongside far larger names.

Ready when you are.

Five steps to live.

1Review with Emily. 2Agree which activities you actually want to run. 3Lock the category and positioning work. 4Agree start date and contract. 5Appointment announcement out first.

Please open on a desktop or laptop

Enter password

Category Authority

The science is a decade ahead.
The shelf it sits on is not.